CAMPIA, IVANA
 Distribuzione geografica
Continente #
NA - Nord America 2.169
EU - Europa 1.172
AS - Asia 525
AF - Africa 33
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
Totale 3.928
Nazione #
US - Stati Uniti d'America 2.127
CN - Cina 342
SE - Svezia 211
IT - Italia 198
AT - Austria 158
IE - Irlanda 137
FR - Francia 100
FI - Finlandia 93
UA - Ucraina 91
DE - Germania 64
KR - Corea 48
PL - Polonia 46
IN - India 33
SN - Senegal 31
CA - Canada 30
VN - Vietnam 25
JP - Giappone 24
GB - Regno Unito 23
RU - Federazione Russa 15
SG - Singapore 13
TW - Taiwan 13
MX - Messico 12
AU - Australia 11
EU - Europa 9
BE - Belgio 8
CH - Svizzera 6
NL - Olanda 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
ID - Indonesia 5
ES - Italia 4
UZ - Uzbekistan 4
BR - Brasile 3
DK - Danimarca 3
TR - Turchia 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
IR - Iran 2
NO - Norvegia 2
RO - Romania 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BY - Bielorussia 1
GR - Grecia 1
HK - Hong Kong 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 3.928
Città #
Chandler 263
Beijing 195
Fairfield 169
Vienna 158
Houston 151
Ashburn 145
Dublin 137
Ann Arbor 125
Woodbridge 97
Dearborn 73
Wilmington 73
Villeurbanne 72
Nyköping 71
Seattle 58
Torino 58
Cambridge 56
Medford 50
Jacksonville 49
Pisa 48
Princeton 46
Warsaw 42
Redwood City 28
Fremont 20
Boardman 18
New York 18
Shanghai 18
Toronto 17
Phoenix 16
Dong Ket 14
San Mateo 14
Nanjing 12
Washington 11
San Diego 10
Boston 9
Munich 9
Tokyo 9
Guangzhou 8
Hefei 8
Pune 8
Taipei 8
Hangzhou 7
Turin 7
Brussels 6
Caravino 6
Changchun 6
Fuzhou 6
Helsinki 6
Moscow 6
Silver Spring 6
Buffalo 5
Chengdu 5
Chongqing 5
Düsseldorf 5
Jakarta 5
Milan 5
Montréal 5
Xian 5
Bethesda 4
Camporosso 4
Falls Church 4
Jinan 4
Mexico 4
Siena 4
Verona 4
Bogotá 3
Changsha 3
Cincinnati 3
Garza García 3
Guiyang 3
Irvine 3
Norwalk 3
Philadelphia 3
Provo 3
Santa Clara 3
Tianjin 3
Wuhan 3
Zhengzhou 3
Alba 2
Antwerpen 2
Appiano Gentile 2
Bergamo 2
Berlin 2
Birmingham 2
Bogen 2
Borgomanero 2
Chaoyang 2
Des Moines 2
Dornburg 2
Erie 2
Jouy-le-Moutier 2
Kunming 2
Melbourne 2
Mexico City 2
Nanchang 2
Napoli 2
New Haven 2
Niagara Falls 2
North Brunswick 2
Paris 2
Perth 2
Totale 2.600
Nome #
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 291
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 259
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells 210
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. 188
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells 173
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells 152
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells 151
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 138
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells 128
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 118
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL) 112
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 112
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells 103
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells 101
Classical inhibitors of NOX NAD(P)H oxidases are not specific 100
Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. 95
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells 92
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 89
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS 88
Cardiac glycosides as new modulators of cholesterol metabolism 87
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells 86
Digoxin and ouabain increase the synthesis of cholesterol in human liver cells 84
Pleiotropic Effects of Cardioactive Glycosides. 82
null 80
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. 76
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 73
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. 70
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 65
Digoxin and oubain increase the synthesis of cholesterol in human liver cells 65
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells 65
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 64
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 64
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 62
Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells 60
Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors? 55
Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis 48
The “LDL-masked doxorubicin”: an effective strategy for drug delivery across hypoxic blood brain barrier 44
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells 40
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells. 37
Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. 31
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) 24
Totale 4.062
Categoria #
all - tutte 9.594
article - articoli 0
book - libri 0
conference - conferenze 3.605
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019206 0 0 0 0 0 0 0 0 0 0 131 75
2019/2020686 37 42 31 82 58 135 79 47 50 63 32 30
2020/2021456 47 31 21 43 74 25 27 28 47 26 32 55
2021/2022538 13 14 17 55 8 14 52 25 17 64 173 86
2022/2023718 78 68 16 64 74 194 47 34 83 9 34 17
2023/2024269 38 49 21 14 14 93 9 17 1 13 0 0
Totale 4.062